Short interest in Immune Therapeutics Inc (OTC:IMUN) increased during the last reporting period, rising from 256.00 to 257.00. This put -% of the company's publicly available shares short.

Short interest for Immune Therapeutics Inc gives investors a sense of the degree to which investors are betting on the decline of Immune Therapeutics Inc's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 794.00 shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.